Changes in HDL-cholesterol and lipoprotein Lp(a) after 6-month treatment with finasteride in males affected by benign prostatic hyperplasia (BPH).

Denti, L; Pasolini, G; Cortellini, P; Sanfelici, L; Benedetti, R; Cecchetti, A; Ferretti, S; Bruschieri, L; Ablondi, F; Valenti, G

Denti, L; Pasolini, G; Cortellini, P; Sanfelici, L; Benedetti, R; Cecchetti, A; Ferretti, S; Bruschieri, L; Ablondi, F; Valenti, G.

Affiliation

Denti L; Department of Geriatrics, Cattedra di Gerontologia e Geriatria, Università di Parma, Via Don Bosco 2, 43100, Parma, Italy.

Atherosclerosis ; 152(1): 159-66, 2000 Sep.

Article in En | MEDLINE | ID: mdl-10996351

Subject(s)

Cholesterol, HDL/blood; Enzyme Inhibitors/administration & dosage; Finasteride/administration & dosage; Lipoprotein(a)/drug effects; Prostatic Hyperplasia/drug therapy; Aged; Analysis of Variance; Cholesterol, HDL/drug effects; Drug Administration Schedule; Enzyme-Linked Immunosorbent Assay; Humans; Lipoprotein(a)/blood; Male; Middle Aged; Prostatic Hyperplasia/diagnosis; Reference Values

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Hyperplasia / Lipoprotein(a) / Finasteride / Enzyme Inhibitors / Cholesterol, HDL Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies Limits: Aged / Humans / Male / Middle aged Language: En Journal: Atherosclerosis Year: 2000 Document type: Article

Search on Google

XML

PubMed Links